Prostate cancer decisions — 2022

The Board has remanded the claims for diabetes mellitus type II, prostate cancer, and hypertension due to insufficient information regarding exposure to herbicide agents during service. The Veteran's claims will be further developed to confirm or deny his alleged exposure in Korea.

The Veteran's prostate cancer is denied as there is no evidence of in-service exposure to herbicide agents or a relationship between his military service and the condition.

The Board denied service connection for prostate cancer, finding no evidence of herbicide exposure and insufficient evidence linking the condition to service.

The Veteran's appeal for a higher rating for tinnitus has been withdrawn.,The Board is remanding the issues of service connection for cervical spine disability, left knee disability, right knee disability, acquired psychiatric disorder (including depressive disorder, chronic anxiety, and posttraumatic stress disorder (PTSD)), type II diabetes mellitus, prostate cancer, erectile dysfunction, bilateral upper extremity peripheral neuropathy, bilateral lower extremity peripheral neuropathy, and bilateral hearing loss.,The Veteran's appeal for a higher rating for low back disability is also being remanded.

The Board has remanded the case due to inadequate opinions regarding exposure to contaminated water, non-ionizing radiation, and EMFs. The Veteran's prostate cancer is being reviewed again for a new opinion from an oncology specialist.

The Veteran's appeals for higher ratings and the discontinuance of a 100 percent rating for prostate cancer residuals have been dismissed due to his withdrawal of the appeal in its entirety.

The Veteran's prostate cancer is granted as service connected due to exposure at Camp Lejeune, with reasonable doubt resolved in his favor.

The Board has granted service connection for prostate cancer as due to herbicide (Agent Orange) exposure, based on the Veteran's in-service exposure at Nakhon Phanom Royal Thai Air Force Base (NKB) in Thailand from June 1973 to August 1974.

The Board has denied service connection for a right shoulder condition, left shoulder condition, prostate cancer, and diabetes mellitus, type II. Service connection for a right inguinal hernia is granted.

The Veteran's appeals for service connection on four different conditions have been dismissed due to his death while the appeal was pending.

The Board has determined that additional records are needed and a VA examination is required to determine the etiology of various disabilities, including MRSA, legal blindness, gout, lower back disability, left knee, right knee disability, memory loss, prostate cancer, lymphoma, and bilateral hammer toes. The Veteran's claims for compensation under 38 U.S.C. § 1151 for MRSA are also remanded.

The Board has determined that the Veteran's prostate cancer is at least as likely as not related to his exposure to carcinogens while stationed at Camp Lejeune during his active service, and thus grants service connection for prostate cancer.

The Board has remanded the cases for additional medical opinions regarding service connection for prostate cancer and malignant neoplasms of soft tissue (pelvis). The opinions are needed to address whether these conditions are related to the Veteran's reported exposure to paint fumes and dust on munitions during his active service.

The Veteran's residuals of prostate cancer are rated at 60 percent effective January 1, 2017.

The Veteran's prostate cancer residuals, post radiation therapy, do not warrant a rating in excess of 10 percent.,The Veteran's erectile dysfunction does not meet the criteria for a compensable disability rating.,The Veteran's PTSD symptoms do not meet the criteria for an initial disability rating in excess of 50 percent.

The Board has remanded the Veteran's claims of service connection for prostate cancer, diabetes mellitus type II, and peripheral neuropathy due to his exposure to herbicide agents/Agent Orange during his military service in Korea.

The Board denied service connection for diabetes mellitus type II and prostate cancer, finding no evidence of exposure to herbicide agents or actual exposure during the appellant's service. The diseases were not shown as chronic in service, nor are there established continuity of symptomatology.

The Veteran's prostate cancer was not incurred in or aggravated by service, and the Board denied his claim for service connection.

The Veteran's claim for an effective date prior to August 12, 2018, for the award of service connection for prostate cancer is denied. The earliest possible effective date under VA regulations is assigned as the date VA received his intent to file a claim on August 12, 2018.

The Veteran's claim for service connection for prostate cancer is denied as there is no evidence of herbicide agent or ionizing radiation exposure during service, and the medical opinion does not support a link between his current condition and service.